Adaptimmune Therapeutics plc (ADAP) PT Lowered to $17 at Citi
Tweet
Share
E-mailGet Alerts ADAP Hot Sheet
Price: $0.05 --0%
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 45
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 45
Join SI Premium – FREE
Citi lowered its price target on Adaptimmune Therapeutics plc (NASDAQ: ADAP) to $17.00 (from $18.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Safehold (SAFE) PT Lowered to $13 at Truist Securities
- Adicet Bio Inc. (ACET) PT Raised to $28 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
